Study to Evaluate Safety and Efficacy of PF-06700841 in Subjects with Moderate to Severe Plaque Psoriasis
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of PF-06700841 in Subjects with Moderate to Severe Plaque Psoriasis
Category & Conditions: Skin Diseases and Conditions
Medicine: PF-06700841
ClinicalTrials.gov Identifier (NCT): NCT02969018
Protocol ID: B7931004
PrintDownloadOpen Plain Language Summary Result: Click here